FDA Releases Summaries of Pediatric Study Reviews for AGRYLIN, CLOLAR, and DIFLUCAN

Summary

The FDA is making available summaries of medical and clinical pharmacology reviews of pediatric studies for AGRYLIN, CLOLAR, and DIFLUCAN, in compliance with the Best Pharmaceuticals for Children Act (BPCA). This is the first time the agency has made these summaries publicly available.